Fairchem Organics Ltd Q4 FY26 Earnings Analysis
Published 17 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.0K Cr
Price
₹701
Market Cap
₹1.0K Cr
P/E Ratio
66.5
Earnings Summary
Current capacity is 80,000 tonnes with ~65-66% utilization; expected to reach over 95% utilization in next two years. - Addition of new 40,000 tonnes capacity in progress; novel product plant to be commissioned in Q2. - Revenue target of Rs. The company targets to improve EBIT margins to around 8% in the near term with volume growth, rupee devaluation, and energy-saving initiatives supporting margin expansion.
📊 Revenue & Sales Performance
- →Current capacity is 80,000 tonnes with ~65-66% utilization; expected to reach over 95% utilization in next two years.
- →Addition of new 40,000 tonnes capacity in progress; novel product plant to be commissioned in Q2.
- →Revenue target of Rs. 800-1,000 crores from new capacity expected within five years.
- →Long-term vision aims for Rs. 2,000 crores revenue by FY’30.
- →Export contribution expected to grow from current 8-10% to about 20% by FY’27.
- →Volume growth: FY’23 volume was 54,000 tonnes; FY’24 increased to 63,000 tonnes; FY’25 volume around 54,000 tonnes; FY’26 volume was 44,000 tonnes.
- →Expect capacity utilization to reach 75-80% and 40,000 tonnes capacity to be fully utilized in five years.
- →Margins and volume growth expected to improve with export tailwinds, rupee depreciation, and energy-saving initiatives.
📈 Profitability & Margins
- →The company targets to improve EBIT margins to around 8% in the near term with volume growth, rupee devaluation, and energy-saving initiatives supporting margin expansion.
- →Operating leverage expected as plant utilization increases from current ~65% to over 95% in the next two years, which will further boost margins.
- →Margins could potentially reach double digits with sustained volume growth and cost efficiencies.
- →New product launches (40,000 tonnes capacity addition) expected by FY’27-28, contributing to higher revenue (Rs. 800-1000 crores) with better margins (15-18%).
- →Export share expected to grow from ~9% to 20% by FY’27, benefiting from favorable currency and reduced Chinese dumping.
- →Long-term revenue target around Rs. 2000 crores in 5+ years driven by increased capacity and new product streams.
- →Energy audit and cost optimization measures are ongoing, expected to improve operating profits over time.
🏗️ Capital Expenditure Plans
- →No major CAPEX planned for FY2027 except for energy-saving initiatives based on audit results; investments will be made only if payback is less than four years.
- →CAPEX for FY2028 depends on the uptake of a new product; if the product gains traction, investment will follow; current business does not require CAPEX.
- →Recently incurred Rs. 20-25 crores CAPEX for the first phase of commissioning a new product plant with 40,000 tonnes capacity, phased as demand grows.
- →Bypass fat plant to start operation next month, new specialty chemical product plant to start by end of Q2.
- →Overall focus is on improving top-line growth rather than aggressive expansion at present.
💰 Fundraising & Capital Structure
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Fairchem Organics Ltd Q4 FY26 results?
Current capacity is 80,000 tonnes with ~65-66% utilization; expected to reach over 95% utilization in next two years. - Addition of new 40,000 tonnes capacity in progress; novel product plant to be commissioned in Q2. - Revenue target of Rs. The company targets to improve EBIT margins to around 8% in the near term with volume growth, rupee devaluation, and energy-saving initiatives supporting margin expansion.
What is Fairchem Organics Ltd share price analysis?
Fairchem Organics Ltd currently shows a neutral. The stock trades at a P/E of 66.5 with a market cap of ₹1,005 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fairchem Organics Ltd planning capital expenditure?
No major CAPEX planned for FY2027 except for energy-saving initiatives based on audit results; investments will be made only if payback is less than four years. - CAPEX for FY2028 depends on the uptake of a new product; if the product gains traction, investment will follow; current business does not require CAPEX. - Recently incurred Rs.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.